Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
Top Cited Papers
Open Access
- 29 November 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (5), 1388-1398
- https://doi.org/10.1002/art.33465
Abstract
Objective To assess prospectively the rates and to explore predictors of spinal radiographic progression over 2 years in a cohort of patients with early axial spondylarthritis (SpA). Methods Two hundred ten patients with axial SpA from the German Spondyloarthritis Inception Cohort were selected for this analysis based on the availability of radiographs at baseline and after 2 years of followup. Spinal radiographs were scored by 2 trained readers in a blinded, randomly selected order according to the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). Spinal radiographic progression was defined as worsening of the mean mSASSS by ≥2 units over 2 years. Results Among the patients with axial SpA, 14.3% showed spinal radiographic progression after 2 years (20% of those with AS and 7.4% of those with nonradiographic axial SpA). The following parameters were independently associated with spinal radiographic progression: presence of syndesmophytes at baseline (odds ratio [OR] 6.29, P < 0.001), elevated levels of markers of systemic inflammation (for the erythrocyte sedimentation rate, OR 4.04, P = 0.001; for C‐reactive protein level time‐averaged over 2 years, OR 3.81, P = 0.001), and cigarette smoking (OR 2.75, P = 0.012). These associations were confirmed by multivariate logistic regression analysis. No clear association with spinal radiographic progression was observed for HLA–B27 status, sex, age, disease duration, Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index, presence of peripheral arthritis, enthesitis, psoriasis, treatment with nonsteroidal antiinflammatory drugs, or treatment with disease‐modifying antirheumatic drugs at baseline. Conclusion The presence of radiographic damage at baseline (syndesmophytes), elevated levels of acute‐phase reactants, and cigarette smoking were all independently associated with spinal radiographic progression in patients with early axial SpA.Keywords
This publication has 48 references indexed in Scilit:
- Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritisAnnals Of The Rheumatic Diseases, 2011
- Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA–DRB1 shared epitope, regardless of rheumatoid factor or anti–cyclic citrullinated peptide antibody statusArthritis & Rheumatism, 2010
- Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 yearsArthritis Research & Therapy, 2009
- Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitisArthritis Care & Research, 2009
- Rheumatoid arthritis and smoking: putting the pieces togetherArthritis Research & Therapy, 2009
- Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesAnnals Of The Rheumatic Diseases, 2007
- Cigarette smoking and radiographic progression in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?Annals Of The Rheumatic Diseases, 2007
- Consensus statement on the use of rituximab in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2006
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984